Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?

Have you been paying attention to shares of Cardinal Health (CAH)? Shares have been on the move with the stock up 1.7% over the past month. The stock hit a new 52-week high of $244.87 in the previous session. Cardinal has gained 15.7% since the start of the year compared to the 1.1% move for the Zacks Medical sector and the 4.7% return for the Zacks Medical - Dental Supplies industry.

What's Driving the Outperformance?

The stock has an impressive record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on April 30, 2026, Cardinal reported EPS of $3.17 versus consensus estimate of $2.8.

For the current fiscal year, Cardinal is expected to post earnings of $12.04 per share on $256.24 in revenues. Meanwhile, for the next fiscal year, the company is expected to earn $13.48 per share on $278.73 in revenues. This represents a year-over-year change of 11.74% and 8.78%, respectively.

Valuation Metrics

While Cardinal has moved to its 52-week high in the recent past, investors need to be asking, what is next for the company? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.

On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.

Cardinal has a Value Score of A. The stock's Growth and Momentum Scores are A and F, respectively, giving the company a VGM Score of A.

In terms of its value breakdown, the stock currently trades at 19.7X current fiscal year EPS estimates, which is a premium to the peer industry average of 18.1X. On a trailing cash flow basis, the stock currently trades at 20.4X versus its peer group's average of 13.2X. Additionally, the stock has a PEG ratio of 1.16. This is good enough to put the company in the top echelon of all stocks we cover from a value perspective, making Cardinal an interesting choice for value investors.

Zacks Rank

We also need to look at the Zacks Rank for the stock, as this supersedes any trend on the style score front. Fortunately, Cardinal currently has a Zacks Rank of #2 (Buy) thanks to a solid earnings estimate revision trend.

Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cardinal meets the list of requirements. Thus, it seems as though Cardinal shares could have potential in the weeks and months to come.

How Does CAH Stack Up to the Competition?

Shares of CAH have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is McKesson Corporation (MCK). MCK has a Zacks Rank of #2 (Buy) and a Value Score of A, a Growth Score of B, and a Momentum Score of A.

Earnings were strong last quarter. McKesson Corporation beat our consensus estimate by 5.19%, and for the current fiscal year, MCK is expected to post earnings of $44.35 per share on revenue of $431.86 billion.

Shares of McKesson Corporation have gained 9.9% over the past month, and currently trade at a forward P/E of 19.65X and a P/CF of 19.12X.

The Medical - Dental Supplies industry is in the top 16% of all the industries we have in our universe, so it looks like there are some nice tailwinds for CAH and MCK, even beyond their own solid fundamental situation.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research